All Updates

All Updates

icon
Filter
Product updates
QuantHealth reports 85% accuracy in clinical trial simulations
AI Drug Discovery
Aug 20, 2024
This week:
Partnerships
T-Mobile partners with OpenAI to develop AI-powered customer service platform
Generative AI Applications
Yesterday
Partnerships
Runway partners with Lionsgate to develop AI video tools using studio's movie catalog
Generative AI Applications
Sep 18, 2024
Funding
QMill raises EUR 4 million in seed funding to provide quantum computing industrial applications
Quantum Computing
Sep 18, 2024
Product updates
QuiX Quantum launches 'Bia' quantum cloud computing service for quantum solutions
Quantum Computing
Sep 18, 2024
Partnerships
Oxford Ionics and Infineon Technologies partner to build portable quantum computer for Cyberagentur
Quantum Computing
Sep 18, 2024
Product updates
Partnerships
Tencent Ai Lab launches EzAudio AI for text-to-audio generation with Johns Hopkins University
Foundation Models
Sep 18, 2024
Funding
TON secures USD 30 million in investment from Bitget and Foresight Ventures
Web3 Ecosystem
Sep 18, 2024
Funding
Hemi Labs raises USD 15 million in funding to launch blockchain network
Web3 Ecosystem
Sep 18, 2024
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Machine Learning Infrastructure
Sep 18, 2024
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Data Infrastructure & Analytics
Sep 18, 2024
AI Drug Discovery

AI Drug Discovery

Aug 20, 2024

QuantHealth reports 85% accuracy in clinical trial simulations

Product updates

  • QuantHealth, an AI-powered clinical trial design company, has announced that its Clinical-Simulator system has achieved 85% accuracy in predicting clinical trial outcomes. The company uses AI technology to forecast individual patient responses within clinical trials, combining data from 350 million patients and over 700,000 drug entities.

  • The Clinical-Simulator can simulate more than 5,000 protocol variations within minutes, identifying factors most likely contributing to trial success. It predicts Phase II trial outcomes with 88% accuracy and Phase III trial outcomes with 83.2% accuracy, significantly higher than current industry success rates.

  • QuantHealth claims its technology has enabled cost reductions of more than USD 215 million for a pharmaceutical partner's respiratory disease team. The company reports improved accuracy rates across various therapeutic areas, including oncology, immune and inflammation, gastroenterology, and respiratory diseases, compared to national averages.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.